TBC1D10B and neoplasm: In this paper, our results show that the DEGs related to higher TBC1D10B levels are enriched specifically in the cell cycle, MET-associated pathway, and ECM regulation, suggesting that an alteration in TBC1D10B expression may be a cause of changing both cancer cells’ phenotypes and the tumor microenvironment.